JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES)

• 无栏目 • Previous Articles     Next Articles

PDGFC variant mRNA expression in renal cell carcinoma cells

LIU Juanping1, LIU Zhaoxu1，2, XU Zhonghua2, LIU Cheng2, ZHOU Zunlin2, YAN Lei2, FAN Yidong2

  

  1. （1. School of Nursing，Shandong University, Jinan 250012， China;
    2. Department of Urology, Qilu Hospital of Shandong University, Jinan 250012， China）
  • Received:1900-01-01 Revised:1900-01-01 Online:2009-03-16 Published:2009-03-16

PDF (PC)

250

Abstract: To explore expressions of Plateletderived growth factor C(PDGFC) and a novel spliced variant (designated as PDGFCb) of human PDGFC in clear cell renal cell carcinoma and to explore its significance. MethodsUsing semiquantitative reverse transcriptionpolymerase chain reaction (RTPCR) method, expressions of PDGFC and PDGFCb in 12 clear cell renal cell carcinoma tissues and matched adjacent normal tissues were determined. The relationship between expressions of PDGFC and PDGFCb and the impact of Cisplatin on mRNA expression of PDGFC and PDGFCb in the renal cell line was analyzed. ResultsCompared with the matched normal tissues, 9 of the 12 samples had a decreased PDGFCb mRNA expression, 10 had an increased PDGFC expression, and 11 had an increased PDGFC/Cb expression. On the mRNA level, Cisplatin downregulated expressions of PDGFC and PDGFCb and the effect on the latter was dosedependently. Expressions of PDGFC and PDGFCb between the carcinoma tissues and the matched normal tissues were significantly different and expression of PDGFC was upregulated in the carcinoma tissues. ConclusionPDGFCb presents a reverse regulation on the secretion of PDGFC, and this might be involved in RCC tumorigenesis. The downregulation of PDGFC and Cb induced by Cisplatin provides a potential pathway for research of the tumorigenesis of renal cell carcinoma.

Key words: Kindey neoplasms, Cisplatin, Plateletderived growth factorC

CLC Number: 

  • R737.11
[1] SUO Dongyang, SHEN Fei, GUO Hao, LIU Lichang, YANG Huimin, YANG Xiangdong. Expression and mechanism of Tim-3 in animal model of drug-induced acute kidney injury [J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 1-6.
[2] ZHAO Ming, NIU Jie, LI Fangqin, WANG Aihong, PANG Qiuxia, CHEN Meini, ZHOU Lizhen, ZHAO Jumei. Effects of salinomycin combined with cisplatin on the proliferation and apoptosis of human gastric cancer cell line MKN-45 [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(5): 31-35.
[3] CUI Yong, ZHANG Rongxiang, WANG Fuli, WANG Guoying, FENG Jianlin, ZHANG Haixia. Clinical efficacy of BSD2000 deep hyperthermia combined with chemotherapy of TP regimen for advanced ovarian cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(7): 53-57.
[4] YANG Lu, LIU Yanguo, LI Jisheng, WANG Xiuwen. Effect of bufalin on chemosensitivity to cisplatin in non-small cell lung cancer and the underlying mechanisms [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(3): 6-11.
[5] ZHANG Min, WANG Xuefeng. Killing effect of apoptotic-tumor-cell-loaded dendritic cells on laryngeal carcinoma cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(7): 32-36.
[6] ALIMUJIANG·Stiwaerdi, ZHANG Tao, PATIGULI·Aerxiding, LIU Li. Clinical analysis of recombinant human endostatin combined with gemcitabine and  cisplatin therapy in advanced non-small cell lung cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(3): 95-98.
[7] JIA Zong-yang, ZHANG Xiang-ning, JIN Yan-hui, WEI Mei-ling. Effects of PD98059 combined with cisplatin derivative on human ovarian carcinoma cell SKOV3 [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(2): 27-32.
[8] QIAO Zhen1, LIU Pei-shu2, HAN Bing1, WANG Yu1. Smac mimic potentiates cisplatin-induced cell apoptosis of
ovarian cancer cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(6): 61-.
[9] YANG Ning, HAN Jun-qing, SHENG Wei. Relationship of expressions of RRM1 and ERCC1 proteins with  response and prognosis in advanced NSCLC patients receiving  cisplatin combined with gemcitabine chemotherapy [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(6): 89-93.
[10] QI Lei, LI Jian-min, XIANG Long-zhan, YANG Qiang. Effects of high-concentration distilled water and cisplatin on  osteosarcoma cells in a local and shorttime manner [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(2): 75-78.
[11] XU Yan-yan1， YU Hui-min2, JIANG Na3. Effect of glutathione combined with platinum derivative on gastric cancer cell lines in vitro [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(8): 42-46.
[12] ZU Zengyan1, ZHANG Guiyu1, MA Benhong1, WANG Hongxia2 . Inhibitory effect of rosiglitazone combined with cisplatin on the growth of endometrial carcinoma in Nude Mice [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(5): 62-66.
[13] JIA Zheng-fei,FENG Yong, ZHONG Qin,XIA Xiao-tian. Concurrent chemoradiotherapy with docetaxel/cisplatin for local advanced non-small cell lung cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2008, 46(9): 898-900.
[14] WU Ming-sheng,WANG Ping,LIN Jun-hao,WANG Qian,WU Shu-ming. ERCC1 expression and cisplatin based adjuvant chemotherapy in non-small cell lung cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2008, 46(6): 556-560.
[15] XU Shu-yuan ,XIAO Dong-jie,LUAN Ying-zi,WANG Yun-shan,WANG Lin,SHI Kai. Regulatory mechanism of cell cycle block and apoptosis in p53 mutated gastric cancer cells during cisplatin stress [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2008, 46(5): 478-480.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd